Hematopoietic stem cell transplantation

References

• BryderDRossiDJWeissmanILHematopoietic stem cells: the paradigmatic tissue-specific stem cellAm J Pathol200616933834616877336
   PubMed Web of Science ®Google Scholar
• ShizuruJANegrinRSWeissmanILHematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid systemAnnu Rev Med20055650953815660525
   PubMed Web of Science ®Google Scholar
• OgawaMDifferentiation and proliferation of hematopoietic stem cellsBlood199381284428538499622
   PubMed Web of Science ®Google Scholar
• AlcornMJHolyoakeTLRichmondLCD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicityJ Clin Oncol199614183918478656252
   PubMed Web of Science ®Google Scholar
• ZandstraPWLauffenburgerDAEavesCJA ligand-receptor signaling threshold model of stem cell differentiation control: a biologically conserved mechanism applicable to hematopoiesisBlood2000961215122210942360
   PubMed Web of Science ®Google Scholar
• PodestaMTransplantation hematopoiesisCurr Opin Hematol2001833133611604571
   PubMed Web of Science ®Google Scholar
• LanzkronSMCollectorMISharkisSJHoming of long-term and short-term engrafting cells in vivoAnn N Y Acad Sci1999872485410372110
   PubMed Web of Science ®Google Scholar
• AiutiAWebbIJBleulCSpringerTGutierrez-RamosJCThe chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral bloodJ Exp Med19971851111208996247
   PubMed Web of Science ®Google Scholar
• AiutiATavianMCipponiAExpression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lymphohematopoietic progenitorsEur J Immunol1999291823183110382744
   PubMed Web of Science ®Google Scholar
• PeledAKolletOPonomaryovTThe chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34+ cells: role in transendothelial/stromal migration and engraftment of NOD/SCID miceBlood2000953289329610828007
   PubMed Web of Science ®Google Scholar
• KolletOSpiegelAPeledARapid and efficient homing of human CD34+CD38(−/low) CXCR4+ stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) miceBlood2001973283329111342460
   PubMed Web of Science ®Google Scholar
• LanzkronSMCollectorMISharkisSJHematopoietic stem cell tracking in vivo: a comparison of short-term and long-term repopulating cellsBlood1999931916192110068664
   PubMed Web of Science ®Google Scholar
• MahmudNDevineSMWellerKPThe relative quiescence of hematopoietic stem cells in nonhuman primatesBlood2001973061306811342431
   PubMed Web of Science ®Google Scholar
• BurtRKTraynorABurnsWHematopoietic stem cell transplantation of multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosusCancer Treat Res199910115718410800649
   PubMedGoogle Scholar
• BoniniCFerrariGVerzelettiSHSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemiaScience1997276171917249180086
   PubMed Web of Science ®Google Scholar
• CohenJLBoyerOSalomonBPrevention of graft-versus-host disease in mice using a suicide gene expressed in T lymphocytesBlood199789463646459192790
   PubMed Web of Science ®Google Scholar
• GandyKLWeissmanILTolerance of allogeneic heart grafts in mice simultaneously reconstituted with purified allogeneic hematopoietic stem cellsTransplantation1998652953049484743
   PubMed Web of Science ®Google Scholar
• QuesenberryPJDoonerGColvinGAbediMStem cell biology and the plasticity polemicExp Hematol20053338939415781328
   PubMed Web of Science ®Google Scholar
• AbrahamsenIWSommeSHeldalDEgelandTKvaleDTjonnfjordGEImmune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host diseaseHaematologica200590869315642674
   PubMed Web of Science ®Google Scholar
• KolbHJMittermullerJClemmCDonor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patientsBlood199076246224652265242
   PubMed Web of Science ®Google Scholar
• AnasettiCHansenJAEffect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donorsTransfus Sci19941522123010155543
   PubMedGoogle Scholar
• AnasettiCPetersdorfEWMartinPJWoolfreyAHansenJATrends in transplantation of hematopoietic stem cells from unrelated donorsCurr Opin Hematol2001833734111604572
   PubMed Web of Science ®Google Scholar
• GluckmanEBroxmeyerHAAuerbachADHematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical siblingN Engl J Med1989321117411782571931
   PubMed Web of Science ®Google Scholar
• KurtzbergJLaughlinMGrahamMLPlacental blood as a source of hematopoietic stem cells for transplantation into unrelated recipientsN Engl J Med19963351571668657213
   PubMed Web of Science ®Google Scholar
• WagnerJEKernanNASteinbuchMBroxmeyerHEGluckmanEAllogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant diseaseLancet19953462142197616801
   PubMed Web of Science ®Google Scholar
• FischerALandaisPFriedrichWEuropean experience of bone-marrow transplantation for severe combined immunodeficiencyLancet19903368508541976883
   PubMed Web of Science ®Google Scholar
• LucarelliGGalimbertiMPolchiPBone marrow transplantation in patients with thalassemiaN Engl J Med19903224174212300104
   PubMed Web of Science ®Google Scholar
• BahceciEReadEJLeitmanSCD34+ cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignanciesBr J Haematol200010840841410691874
   PubMed Web of Science ®Google Scholar
• BraineHGSensenbrennerLLWrightSKTutschkaPJSaralRSantosGWBone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusionBlood1982604204257046847
   PubMed Web of Science ®Google Scholar
• BucknerCDPetersenFBBolonesiBABone marrow donorsFormanSJBlumeKGThomasEDBone Marrow TransplantationBoston, MABlackwell Scientific Publications1994259270
   Google Scholar
• BortinMMBucknerCDMajor complications of marrow harvesting for transplantationExp Hematol1983119169216363112
   PubMed Web of Science ®Google Scholar
• BensingerWSingerJAppelbaumFAutologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factorBlood199381315831637684625
   PubMed Web of Science ®Google Scholar
• SheridanWPBegleyCGJuttnerCAEffect of peripheral-blood progenitor cells mobilised by flgrastim (G-CSF) on platelet recovery after high-dose chemotherapyLancet19923396406441371817
   PubMed Web of Science ®Google Scholar
• HartmannOLe CorrollerAGBlaiseDPeripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trialAnn Intern Med19971266006079103126
   PubMed Web of Science ®Google Scholar
• VellengaEvanAMCroockewitAJAutologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: The Hovon 22 StudyBr J Haematol200111431932611529850
   PubMed Web of Science ®Google Scholar
• WeaverCHHazeltonBBirchRAn analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapyBlood199586396139697579367
   PubMed Web of Science ®Google Scholar
• BensingerWIWeaverCHAppelbaumFRTransplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factorBlood199585165516587534140
   PubMed Web of Science ®Google Scholar
• KorblingMPrzepiorkaDHuhYOAllogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allograftsBlood199585165916657888684
   PubMed Web of Science ®Google Scholar
• SchmitzNDregerPSuttorpMPrimary transplantation of allogeneic peripheral blood progenitor cells mobilized by flgrastim (granulocyte colony-stimulating factor)Blood199585166616727534141
   PubMed Web of Science ®Google Scholar
• CesaroSMarsonPGazzolaMVThe use of cytokine-stimulated healthy donors in allogeneic stem cell transplantationHaematologica200287354112412388
   PubMedGoogle Scholar
• BrownSLDaleDCSpontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cellsBiol Blood Marrow Transplant199733413439502302
   PubMedGoogle Scholar
• HatzimichaelEBenetatosLStebbingJKapsaliEPanayiotopoulouSBourantasKLSpontaneous splenic haematoma in a multiple myeloma patient receiving pegfilgrastim supportClin Lab Haematol20062841641817105496
   PubMedGoogle Scholar
• MasoodNShaikhAJMemonWAIdressRSplenic rupture, secondary to G-CSF use for chemotherapy induced neutropenia: a case report and review of literatureCases J2008141819108744
   PubMedGoogle Scholar
• NuamahNMGokerHKilicYADagmouraHCakmakASpontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (g-csf). A case report and review of the literatureHaematologica200691ECR0816709516
   PubMed Web of Science ®Google Scholar
• FlowersMEParkerPMJohnstonLJComparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trialBlood200210041541912091330
   PubMed Web of Science ®Google Scholar
• MohtyMKuentzMMichalletMChronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized studyBlood20021003128313412384409
   PubMed Web of Science ®Google Scholar
• BradleyMBCairoMSCord blood immunology and stem cell transplantationHum Immunol20056643144615935881
   PubMed Web of Science ®Google Scholar
• WangJCDoedensMDickJEPrimitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assayBlood199789391939249166828
   PubMed Web of Science ®Google Scholar
• HoganCJShpallEJMcNultyOEngraftment and development of human CD34+ -enriched cells from umbilical cord blood in NOD/LtSz-scid/scid miceBlood19979085969207442
   PubMed Web of Science ®Google Scholar
• GrewalSSBarkerJNDaviesSMWagnerJEUnrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?Blood20031014233424412522002
   PubMed Web of Science ®Google Scholar
• DelaneyCHeimfeldSBrashem-SteinCVoorhiesHMangerRLBernsteinIDNotch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitutionNat Med20101623223620081862
   PubMed Web of Science ®Google Scholar
• WangJZhanPOuyangJChenBZhouRYangYUnrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients: a meta-analysisLeuk Res20103481018102220031212
   PubMed Web of Science ®Google Scholar
• GribbenJGZahriehDStephansKAutologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemiaBlood20051064389439616131571
   PubMed Web of Science ®Google Scholar
• MichalletMArchimbaudEBandiniGEuropean Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant RegistryHLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemiaAnn Intern Med19961243113158554226
   PubMed Web of Science ®Google Scholar
• LimZBrandRMartinoRAllogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemiaJ Clin Oncol20102840541120008642
   PubMed Web of Science ®Google Scholar
• HsiehMYChiouTJHungGYYenHJOutcomes of matched sibling and alternative donor stem cell transplantation for 26 children with severe aplastic anemiaInt J Hematol201091546020037749
   PubMed Web of Science ®Google Scholar
• SorrorMLMarisMBStorbRHematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTBlood20051062912291915994282
   PubMed Web of Science ®Google Scholar
• SorrorMLStorerBEMaloneyDGSandmaierBMMartinPJStorbROutcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemiaBlood200811144645217916744
   PubMed Web of Science ®Google Scholar
• FarinaLBrunoBPatriarcaFThe hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantationLeukemia2009231131113819194465
   PubMed Web of Science ®Google Scholar
• MajhailNSBrunsteinCGMcAvoySDoes the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplantsBiol Blood Marrow Transplant20081498599218721761
   PubMed Web of Science ®Google Scholar
• AfessaBPetersSGMajor complications following hematopoietic stem cell transplantationSemin Respir Crit Care Med20062729730916791762
   PubMed Web of Science ®Google Scholar
• MarrKAAntifungal prophylaxis in hematopoietic stem cell transplant recipientsCurr Opin Infect Dis20011442342611964859
   PubMed Web of Science ®Google Scholar
• MeyersJDInfection in bone marrow transplant recipientsAm J Med19868127383090877
   PubMed Web of Science ®Google Scholar
• BoeckhMLeisenringWRiddellSRLate cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunityBlood200310140741412393659
   PubMed Web of Science ®Google Scholar
• AndreiGDeCESnoeckRNovel inhibitors of human CMVCurr Opin Investig Drugs20089132145
   PubMedGoogle Scholar
• LiCRGreenbergPDGilbertMJGoodrichJMRiddellSRRecovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxisBlood199483197119798142663
   PubMed Web of Science ®Google Scholar
• Schmidt-HieberMSchwarckSStrouxAProphylactic iv Igs in patients with a high risk for CMV after allo-SCTBone Marrow Transplant20094418519219151799
   PubMed Web of Science ®Google Scholar
• TuthillMChenFPastonSde La PenaHRusakiewiczSMadrigalAThe prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantationCancer Immunol Immunother2009581481148819466407
   PubMed Web of Science ®Google Scholar
• PastonSJDodiIAMadrigalJAProgress made towards the development of a CMV peptide vaccineHum Immunol20046554454915172455
   PubMed Web of Science ®Google Scholar
• PassRFZhangCEvansAVaccine prevention of maternal cytomegalovirus infectionN Engl J Med20093601191119919297572
   PubMed Web of Science ®Google Scholar
• FilipovichAHWeisdorfDPavleticSNational Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group reportBiol Blood Marrow Transplant20051194595616338616
   PubMed Web of Science ®Google Scholar
• GaleRPBortinMMvan BekkumDWRisk factors for acute graft-versus-host diseaseBr J Haematol1987673974063322360
   PubMed Web of Science ®Google Scholar
• HahnTMcCarthyPLJrZhangMJRisk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemiaJ Clin Oncol2008265728573418981462
   PubMed Web of Science ®Google Scholar
• RembergerMPerssonUHauzenbergerDRingdenOAn association between human leucocyte antigen alleles and acute and chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantationBr J Haematol200211975175912437654
   PubMed Web of Science ®Google Scholar
• CourielDCalderaHChamplinRKomanduriKAcute graft-versus-host disease: pathophysiology, clinical manifestations, and managementCancer20041011936194615372473
   PubMed Web of Science ®Google Scholar
• FirozBFLeeSJNghiemPQureshiAARole of skin biopsy to confirm suspected acute graft-vs-host disease: results of decision analysisArch Dermatol200614217518216490845
   PubMedGoogle Scholar
• GlucksbergHStorbRFeferAClinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donorsTransplantation1974182953044153799
   PubMed Web of Science ®Google Scholar
• PrzepiorkaDWeisdorfDMartinP1994 Consensus Conference on Acute GvHD GradingBone Marrow Transplant1995158258287581076
   PubMed Web of Science ®Google Scholar
• RowlingsPAPrzepiorkaDKleinJPIBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg gradeBr J Haematol1997978558649217189
   PubMed Web of Science ®Google Scholar
• StorbRDeegHJWhiteheadJMethotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemiaN Engl J Med19863147297353513012
   PubMed Web of Science ®Google Scholar
• GreinixHTKnoblerRMWorelNThe effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host diseaseHaematologica20069140540816531267
   PubMed Web of Science ®Google Scholar
• KimSSTreatment options in steroid-refractory acute graft-versus-host disease following hematopoietic stem cell transplantationAnn Pharmacother2007411436144417684033
   PubMed Web of Science ®Google Scholar
• CarlensSRingdenORembergerMRisk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysisBone Marrow Transplant1998227557619827972
   PubMed Web of Science ®Google Scholar
• SullivanKMShulmanHMStorbRChronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppressionBlood1981572672767004534
   PubMed Web of Science ®Google Scholar
• SullivanKMAcute and chronic graft-versus-host disease in manInt J Cell Cloning19864Suppl 1S42S93
   PubMedGoogle Scholar
• HigmanMAVogelsangGBChronic graft versus host diseaseBr J Haematol200412543545415142114
   PubMed Web of Science ®Google Scholar
• StorbRPrenticeRLSullivanKMPredictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblingsAnn Intern Med1983984614666340576
   PubMed Web of Science ®Google Scholar
• SullivanKMWitherspoonRPStorbRAlternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host diseaseBlood1988725555613042042
   PubMed Web of Science ®Google Scholar
• VogelsangGBHow I treat chronic graft-versus-host diseaseBlood2001971196120111222360
   PubMed Web of Science ®Google Scholar
• CutlerCMiklosDKimHTRituximab for steroid-refractory chronic graft-versus-host diseaseBlood200610875676216551963
   PubMed Web of Science ®Google Scholar
• WeisdorfDJNelsonGLeeSJSibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapseBiol Blood Marrow Transplant2009151475147819822308
   PubMed Web of Science ®Google Scholar
• Saarinen-PihkalaUMGustafssonGRingdenONo disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remissionJ Clin Oncol2001193406341411454889
   PubMed Web of Science ®Google Scholar
• ChiodiSSpinelliSRaveraGQuality of life in 244 recipients of allogeneic bone marrow transplantationBr J Haematol200011061461910997973
   PubMed Web of Science ®Google Scholar
• HeinonenHVolinLUutelaAZevonMBarrickCRuutuTQuality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantationAnn Hematol20018013714311320897
   PubMed Web of Science ®Google Scholar
• KissTLAbdolellMJamalNMindenMDLiptonJHMessnerHALong-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantationJ Clin Oncol2002202334234311981005
   PubMed Web of Science ®Google Scholar
• AndrykowskiMAGreinerCBAltmaierEMQuality of life following bone marrow transplantation: findings from a multicentre studyBr J Cancer199571132213297779732
   PubMed Web of Science ®Google Scholar
• BakerFWingardJRCurbowBQuality of life of bone marrow transplant long-term survivorsBone Marrow Transplant1994135895968054912
   PubMed Web of Science ®Google Scholar
• FraserCJBhatiaSNessKImpact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor StudyBlood20061082867287316788100
   PubMed Web of Science ®Google Scholar
• LeeSJFaircloughDParsonsSKRecovery after stem-cell transplantation for hematologic diseasesJ Clin Oncol20011924225211134219
   PubMed Web of Science ®Google Scholar
• HarderHvan GoolARCornelissenJJAssessment of pre-treatment cognitive performance in adult bone marrow or haematopoietic stem cell transplantation patients: a comparative studyEur J Cancer2005411007101615862749
   PubMed Web of Science ®Google Scholar